Assay for detecting hepatitis b virus (hbv)
AssigneeAbbott Molecular Inc.
InventorsDominik Duelli, Wai-Bing Mak, Brian Erickson, Amanda Goldston
Life of this patent
Estimating the term…
Abstract
The disclosure is directed to methods, kits, and compositions, for amplifying and detecting a human hepatitis B virus (HBV) in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
Claims13
A set of oligonucleotide sequences for amplifying and detecting a human hepatitis B virus (HBV) nucleic acid sequence in a sample, which comprises:
- (a) a forward primer oligonucleotide sequence comprising SEQ ID NO:
- 1;
- (b) a reverse primer oligonucleotide sequence comprising SEQ ID NO:
- 2;
- (c) a first probe oligonucleotide sequence comprising SEQ ID NO:
- 3;
- and
- (d) a second probe oligonucleotide sequence comprising SEQ ID NO:
- 4, wherein each of the first and second probe oligonucleotide sequences comprises a detectable label.
A kit for detecting human hepatitis B virus (HBV) in a sample comprising
- (a) a forward primer oligonucleotide sequence comprising SEQ ID NO:
- 1;
- (b) a reverse primer oligonucleotide sequence comprising SEQ ID NO:
- 2;
- (c) a first probe oligonucleotide sequence comprising SEQ ID NO:
- 3;
- (d) a second probe oligonucleotide sequence comprising SEQ ID NO:
- 4;
- (e) reagents for amplifying and detecting nucleic acid sequences;
- and
- (f) instructions for use,
- wherein each of the first and second probe oligonucleotide sequences comprises a detectable label.
A composition for amplifying and detecting a human hepatitis B virus (HBV) in a sample, which comprises:
- (a) a forward primer oligonucleotide sequence comprising SEQ ID NO:
- 1;
- (b) a reverse primer oligonucleotide sequence comprising SEQ ID NO:
- 2;
- (c) a first probe oligonucleotide sequence comprising SEQ ID NO:
- 3;
- and
- (d) a second probe oligonucleotide sequence comprising SEQ ID NO:
- 4, wherein each of the first and second probe oligonucleotide sequences comprises a detectable label.
Dependencies are inferred from the claim text.